Jorgen Lundberg - Mycronic Publ Director, Employee Representative
| MYCR Stock | SEK 386.60 0.80 0.21% |
Insider
Jorgen Lundberg is Director, Employee Representative of Mycronic publ AB since 2019.
| Age | 55 |
| Tenure | 5 years |
| Phone | 46 86 38 52 00 |
| Web | https://www.mycronic.com |
Mycronic Publ Management Efficiency
The company has return on total asset (ROA) of 0.0829 % which means that it generated a profit of $0.0829 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1694 %, meaning that it generated $0.1694 on every $100 dollars invested by stockholders. Mycronic Publ's management efficiency ratios could be used to measure how well Mycronic Publ manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Anna Smieszek | Dometic Group AB | 59 | |
| ME MBA | Nolato AB | 52 | |
| Henrik Enoksson | Nolato AB | N/A | |
| Stefan Fristedt | Dometic Group AB | 57 | |
| Johan Iveberg | Nolato AB | 54 | |
| Per Andersns | Sectra AB | 61 | |
| Olof Pettersson | Nolato AB | N/A | |
| Ella Horvath | Bure Equity AB | N/A | |
| Oskar Hrnell | Bure Equity AB | 36 | |
| Torbjrn MBA | Sectra AB | 66 | |
| Mats Hkansson | Nolato AB | N/A | |
| Brian Garofalow | Dometic Group AB | 46 | |
| Anders Ericsson | Nolato AB | 59 | |
| Eva Karlsson | Dometic Group AB | 57 | |
| Jessica Holmquist | Sectra AB | 46 | |
| Jorgen Karlsson | Nolato AB | 58 | |
| Chialing Hsueh | Dometic Group AB | 60 | |
| Patrik Tolf | Vitrolife AB | 53 | |
| Sophie Hagstromer | Bure Equity AB | 43 | |
| Daniel Forss | Vitrolife AB | 51 | |
| Claes MSc | Sectra AB | 50 | |
Management Performance
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0829 |
Mycronic publ AB Leadership Team
Elected by the shareholders, the Mycronic Publ's board of directors comprises two types of representatives: Mycronic Publ inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mycronic. The board's role is to monitor Mycronic Publ's management team and ensure that shareholders' interests are well served. Mycronic Publ's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mycronic Publ's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anette Mullis, Senior Vice President Human Resources | ||
| Torbjorn Wingardh, Senior Vice President CFO | ||
| Jorgen Lundberg, Director, Employee Representative | ||
| Michael Chalsen, Senior Vice President - Assembly Solutions Global Technologies | ||
| Lena Bavegard, Senior Vice President Operational Excellence | ||
| MSc BA, CFO Devel | ||
| Johan Densjo, Director, Employee Representative | ||
| Thomas Stetter, Senior Vice President General Manager, Business Area Assembly Solutions | ||
| Lena M, VP Functions | ||
| Anna Belfrage, Independent Director | ||
| Johanna Jarl, VP HR | ||
| Niklas Edling, Senior Vice President Strategy and Product Management; Head of Sourcing, Production and Quality | ||
| Ivan MSc, VP Volume | ||
| Ivan Li, Senior Vice President - Assembly Solutions High Volume | ||
| Mikael Wahlsten, Director PG | ||
| Patrik Tigerschiold, Chairman of the Board | ||
| Robert Larsson, Independent Director | ||
| Sven Chetkovich, Acting Director Investor Relations | ||
| UllaBritt FrajdinHellqvist, Independent Member of the Board | ||
| Katarina Bonde, Independent Member of the Board | ||
| Charlott Samuelsson, Senior Vice President, Business Area Pattern Generators | ||
| Anders Lindqvist, President, Chief Executive Officer | ||
| Staffan Dahlstrom, Independent Director | ||
| Clemens Jargon, VP Flex |
Mycronic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mycronic Publ a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0829 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 19.2 B | |||
| Shares Outstanding | 97.53 M | |||
| Shares Owned By Insiders | 0.31 % | |||
| Shares Owned By Institutions | 81.62 % | |||
| Price To Earning | 31.92 X | |||
| Price To Book | 4.52 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mycronic Stock Analysis
When running Mycronic Publ's price analysis, check to measure Mycronic Publ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mycronic Publ is operating at the current time. Most of Mycronic Publ's value examination focuses on studying past and present price action to predict the probability of Mycronic Publ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mycronic Publ's price. Additionally, you may evaluate how the addition of Mycronic Publ to your portfolios can decrease your overall portfolio volatility.